Hi [[ session.user.profile.firstName ]]

Forensic Science

  • Precise Cell Volume Analysis Precise Cell Volume Analysis Elena Lazarova, M.D. Mar 15 2017 6:00 pm UTC 60 mins
    In this webinar, Elena Lazarova, M.D., esteemed clinical biology specialist, researcher and speaker, will discuss the value of precise cell volume measurement in differentiating for blood disorders and its importance in effective patient care. Gaining information about cell volume at different stages in the maturation process provides important insight into a patient’s underlying pathology and may have added value in the diagnosis of blood disorders. Beckman Coulter offers precise cell volume measurement* through the advanced technology and sophisticated algorithms of its uniquely designed DxH 800 hematology systems.

    After the webinar, you will be able to:

    • Cite the challenges laboratories face in differentiating for rare types of anemia
    • Outline the benefits of flow cytometric reticulocyte analysis, available on the DxH 800 platform
    • Understand the value of precise cellular volume measurement* to aid in the differential diagnosis of anemia

    *For research use only and not cleared by the FDA for clinical diagnosis
    **P.A.C.E. credit is available for your participation.

    Dr. Elena Lazarova earned her M.D. degree from the Medical University of Varna, Bulgaria, in 2002. With over 10 years of experience in clinical and laboratory hematology, immunohematology and transfusion medicine, Dr. Lazarova is a highly sought-after teacher and lecturer. She has authored/co-authored seven medical journal articles and has served as primary author on 17 poster and oral presentations at congresses throughout the world. Dr. Lazarova continues her work in laboratory medicine, focusing on hemoglobinopathies and red blood cell pathologies (hereditary spherocytosis and autoimmune hemolytic anemia) in laboratories at Hôpital Erasme in Brussels.
  • Sanger Arrayed CRISPR Screening in partnership with Evotec Sanger Arrayed CRISPR Screening in partnership with Evotec Dr. Hauke Cornils-Res Scientist, Evotec & Shawn Shafer-Dir. Advance Genomics Life Sc. Businessof Merck KGaA,Darmstadt,Germany Mar 16 2017 3:00 pm UTC 75 mins
    CRISPR Cas9 nucleases have revolutionized the field of gene editing and high-throughput lentiviral screens continue to hold ever-increasing promise for both basic research and development of future therapies to benefit human health. Even with such powerful technologies at hand, researchers new to the field may find screening of multiple targets to be challenging and time-consuming. This webinar discusses the Evotec partnership with Merck KGaA,Darmstadt,Germany and the screening services for drug discovery.